21世纪经济报道记者 闫硕在全球医药研发成本高企、成功率低迷的背景下,人工智能(AI)正以前所未有的速度重塑药物发现与开发范式,成为全球科技与医药领域交叉创新的核心赛道。回望2025年,AI制药正从概念验证迈入价值兑现初期,成为全球产业资本、政策制定者与科研机构共同聚焦的战略高地。过去一年,AI制药领域投融资活跃、BD(商务拓展)合作密集、企业布局多元,政策与产业共振,推动行业进入规模化发展的“...
Source Link21世纪经济报道记者 闫硕在全球医药研发成本高企、成功率低迷的背景下,人工智能(AI)正以前所未有的速度重塑药物发现与开发范式,成为全球科技与医药领域交叉创新的核心赛道。回望2025年,AI制药正从概念验证迈入价值兑现初期,成为全球产业资本、政策制定者与科研机构共同聚焦的战略高地。过去一年,AI制药领域投融资活跃、BD(商务拓展)合作密集、企业布局多元,政策与产业共振,推动行业进入规模化发展的“...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.